CAR-T Cell Therapy - personalized cellular Immunotherapy in 2022

被引：0
|
作者：
Niebling, Janina [1 ]
Bethge, Wolfgang [2 ]
Lengerke, Claudia [3 ,4 ]
机构：
[1] Univ Klinikum Tubingen, Qualitatskontrolle Leukapherese Med Klin 2, Tubingen, Germany
[2] Univ Klinikum Tubingen, Zentrums Klin Studien, Tubingen, Germany
[3] Med Fak Tubingen, Tubingen, Germany
[4] Eberhard Karis Univ Tubingen, Humanmed, Tubingen, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2022年 / 147卷 / 23期
关键词：
CAR T cells; chimeric antigen receptor T cells; real world data; registration studies;
D O I：
10.1055/a-1932-8145
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chimeric antigen receptor T cells (CAR T cells) are genetically modified autologous or allogeneic T lymphocytes that target specific antigens and can be used, for example, to fight tumor cells. The registration studies show a high response and remission rate in massively pre-treated patients with aggressive B-cell lymphomas, acute lymphoblastic leukemia or multiple myeloma. The article presents the indications for approval, the clinical implementation and the management of side effects of CAR cell therapy.
引用
收藏
页码：1552 / 1561
页数：10
相关论文
共 50 条
  • [41] CAR-T Cell Therapy for Solid Tumors
    Tony, Liz T.
    Stabile, Andrea
    Schauer, Marc P.
    Hudecek, Michael
    Weber, Justus
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2025,
  • [42] CAR-T CELL IMMUNOTHERAPY IN SOLID TUMORS: COLORECTAL CANCER
    Ponterio, E.
    Valvo, C.
    Cappellari, M.
    Pasquini, L.
    Boe, A.
    Romania, P.
    Petrucci, E.
    Amoreo, C.
    Sciuto, M. R.
    Dattilo, R.
    Pilozzi, E.
    Ricci-Vitiani, L.
    Biffoni, M.
    De Maria, R.
    Haas, T. L.
    HUMAN GENE THERAPY, 2018, 29 (11) : A11 - A11
  • [43] New Approaches in CAR-T Cell Immunotherapy for Breast Cancer
    Wang, Jinghua
    Zhou, Penghui
    TRANSLATIONAL RESEARCH IN BREAST CANCER: BIOMARKER DIAGNOSIS, TARGETED THERAPIES AND APPROACHES TO PRECISION MEDICINE, 2017, 1026 : 371 - 381
  • [44] Expanding CAR-T cell immunotherapy horizons through microfluidics
    Kim, Hyelee
    Kim, Suyeon
    Lim, Hyunjung
    Chung, Aram J.
    LAB ON A CHIP, 2024, 24 (05) : 1088 - 1120
  • [45] Radiation Therapy as a Bridging Strategy in CAR-T Cell Therapy and the Impact of Tumor Control Status at CAR-T Cell Infusion
    Shimizuguchi, T.
    Kanemasa, Y.
    Yagi, Y.
    Hayakawa, S.
    Taguchi, K.
    Ito, K.
    Murofushi, K.
    Sasaki, Y.
    Nakamura, S.
    Matsuda, S.
    Shimoyama, T.
    Toya, T.
    Shimizu, H.
    Najima, Y.
    Kobayashi, T.
    Doki, N.
    Haraguchi, K.
    Okuyama, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S207 - S207
  • [46] Advances and challenges in CAR-T cell-mediated immunotherapy
    Rudra, Dipayan
    Kumar, Himanshu
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2022, 41 (06) : 565 - 566
  • [47] Toxicities of CD19 CAR-T cell immunotherapy
    Hirayama, Alexandre V.
    Turtle, Cameron J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S42 - S49
  • [48] Predicting CAR-T cell Immunotherapy Success through ImmunoPET
    Volpe, Alessia
    Nagle, Veronica L.
    Lewis, Jason S.
    Ponomarev, Vladimir
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 911 - 912
  • [49] CAR-T cells for cancer immunotherapy
    Xie, Yangyang
    Li, Xiaotong
    Wu, Jingyi
    Zeng, Huiling
    Boucetta, Hamza
    Wang, Binru
    Yang, Pei
    He, Wei
    CHINESE CHEMICAL LETTERS, 2023, 34 (09)
  • [50] CAR-T cells for cancer immunotherapy
    Yangyang Xie
    Xiaotong Li
    Jingyi Wu
    Huiling Zeng
    Hamza Boucetta
    Binru Wang
    Pei Yang
    Wei He
    ChineseChemicalLetters, 2023, 34 (09) : 73 - 82
12345